Evidence map›Paper›PMID 39949444›Full record

ArticleCureus2025

Neutrophil-to-Lymphocyte Ratio as a Biomarker for Motor Subtypes in Idiopathic Parkinson's Disease.

Rashid Awan, Okasha Tahir, Shahzad Noor Ul Hadi, Wajeeh Ur Rehman, Fahad Asim

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rashid AwanMedicine, Chiniot General Hospital, Karachi, PAK.
Okasha TahirMedicine, Bacha Khan Medical College, Mardan, PAK.
Shahzad Noor Ul HadiMedicine, Lady Reading Hospital, Peshawar, PAK.
Wajeeh Ur RehmanInternal Medicine, Saidu Group of Teaching Hospitals, Swat, PAK.
Fahad AsimPharmacology and Therapeutics, Faculty of Pharmacy, The University of Lahore, Lahore, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParkinson's disease (PD) is one of the most common neurodegenerative disorders, primarily affecting movement and motor function. Described by the symptoms, including tremors, rigidity, bradykinesia, and postural instability, PD presents clinical heterogeneity in patients, which complicates diagnostic and therapeutic interventions.

objectiveThe study aimed to find the neutrophil-to-lymphocyte ratio (NLR) as a biomarker for motor subtypes in idiopathic PD. MATERIALS AND

methodsThis prospective observational study was conducted at Chiniot General Hospital Karachi, Pakistan, from January 2023 to January 2024. Data were collected from 55 patients suffering from idiopathic PD. Demographic and clinical data were collected for each patient, including age, sex, disease duration, and medications used for PD management.

resultsThere was no significant difference between the tremor-dominant (TD) and postural instability and gait difficulty (PIGD) subtypes in terms of age (p = 0.45), sex distribution (p = 0.62), or disease duration (p = 0.68). However, the Hoehn and Yahr scale, which measures disease severity, was significantly higher in the PIGD subtype (2.9 ± 0.6) compared to the TD subtype (2.4 ± 0.5) with a p-value of 0.03, indicating greater disease severity in the PIGD group. The results indicate that the NLR was significantly higher in the PIGD subtype (3.17 ± 0.89) than in the TD subtype (2.41 ± 0.72), with a p-value of 0.01. This suggests a stronger inflammatory response in the PIGD subtype, which could be linked to greater disease severity in these patients.

conclusionThe NLR can be a potential biomarker for distinguishing motor subtypes in idiopathic PD.

Indexed as

client satisfactionneutrophil countneutrophil-to-lymphocyte ratio (nlr)parkinson's diseasepatient satisfaction

Identifiers

PMID39949444
PMCPMC11824908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.